Data highlight progress toward personalized stem cell therapy for Parkinson's disease

Medical Xpress

Interim clinical findings from the first Phase I/IIa trial using autologous-induced pluripotent stem cell (iPSC)-derived dopamine neuron precursor cells, along with the novel quality-control tools developed to manufacture these individualized therapies, have been presented by Jeanne Loring, Ph.D., Scripps Research, U.S., at the ISSCR 2026 Annual Meeting. ...

전문 보기

이 뉴스, 어떠셨어요?

한 번의 탭으로 반응을 남겨요 · 로그인 불필요

Data highlight progress toward personalized stem cell therapy for Parkinson's disease

이 뉴스, 어떠셨어요?

관련 뉴스

'science' 카테고리 뉴스

Outbreak of diarrhea-causing parasite grows to more than 1,000 cases

Pregnant women may avoid child protection out of fear and mistrust

Why some people are more bothered by low-frequency sounds

Medical Xpress의 다른 기사

AI can't replace mental health therapists. But here's where it might make a difference

Softening aging ovaries could help extend fertility as women get older

Learning to identify new objects reshapes parts of the brain, research finds